Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00907036
What this trial is testing

Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 49
Testing effectiveness (Phase 2)WithdrawnNCT00242931
What this trial is testing

Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute
Testing effectiveness (Phase 2)WithdrawnNCT01047072
What this trial is testing

Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

Who this might be right for
Systemic Scleroderma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002792
What this trial is testing

Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases
Fred Hutchinson Cancer Center 20
Early research (Phase 1)WithdrawnNCT03602872
What this trial is testing

Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis

Who this might be right for
Knee Osteoarthritis
Clinica Santa Clarita, Mexico
Large-scale testing (Phase 3)Study completedNCT03595800
What this trial is testing

Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen

Who this might be right for
Acute LeukemiaNon Hodgkin LymphomaMultiple Myeloma
Institut Paoli-Calmettes 9
Testing effectiveness (Phase 2)Ended earlyNCT04519671
What this trial is testing

Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

Who this might be right for
Perianal Crohn DiseasePerianal FistulaCrohn Disease
Anthony Lembo 25
Testing effectiveness (Phase 2)UnknownNCT01223664
What this trial is testing

Allogenic Bone Marrow Stem Cells Transplantation in Patients With Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT02467387
What this trial is testing

Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure

Who this might be right for
Non-Ischemic Heart Failure
CardioCell LLC 23
Not applicableStudy completedNCT00005892
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Who this might be right for
Fanconi's AnemiaMyelodysplastic SyndromesLeukemia, Nonlymphocytic, Acute+1 more
Fairview University Medical Center
Early research (Phase 1)UnknownNCT03575299
What this trial is testing

Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells

Who this might be right for
Multi-drug Resistant Tuberculosis
Zhinan Yin, Ph.D. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06612944
What this trial is testing

Prophylactic Intervention for Relapse Prevention Post-Allogeneic Transplantation in Very High-Risk MDS Patients Based on IPSS-M Stratification

Who this might be right for
Myelodysplastic Syndromes, Adult
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 40
Not applicableUnknownNCT03672084
What this trial is testing

Allo-HSCT as First-line Consolidation in High-risk PTCL

Who this might be right for
T Cell Lymphoma
Peking University People's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Testing effectiveness (Phase 2)WithdrawnNCT06297629
What this trial is testing

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplantation
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04232241
What this trial is testing

Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid Leukemia in RemissionAcute Lymphoblastic Leukemia in RemissionMyelodysplastic Syndromes
Universitätsklinikum Hamburg-Eppendorf 167
Testing effectiveness (Phase 2)Study completedNCT04926194
What this trial is testing

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant
University Health Network, Toronto 1
Early research (Phase 1)UnknownNCT05487651
What this trial is testing

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

Who this might be right for
NHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more
Athenex, Inc. 36
Not applicableUnknownNCT03684083
What this trial is testing

Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic HSCT Recipients

Who this might be right for
Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 14
Next Page